ImmuPharma (France)

Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial

Robert Zimmer, Hugo R. Scherbarth, Oscar Rillo et al. · Annals of the Rheumatic Diseases · 2012 · 160 citations · Full text

Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: Results of an early phase II clinical trial

Sylviane Muller, Fanny Monneaux, Nicolas Schall et al. · Arthritis & Rheumatism · 2008 · 117 citations

Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo

Juliette Frémaux, Claire Venin, Laura Mauran et al. · Nature Communications · 2019 · 50 citations · Full text

Ureidopeptide GLP-1 analogues with prolonged activity <i>in vivo via</i> signal bias and altered receptor trafficking

Juliette Frémaux, Claire Venin, Laura Mauran et al. · Chemical Science · 2019 · 38 citations · Full text